LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorFirst Hospital of China Medical University

About this trial

This study aims to evaluate the effectiveness of a large language model (LLM)-supported, community-based integrated management model in improving cardiometabolic multimorbidity control among adults with hypertension and coexisting diabetes or dyslipidemia. Adopting an interventional study design, eligible patients will be recruited to compare the disease control indicators between LLM-assisted management and conventional management, so as to verify the effectiveness and safety of the former.

Eligibility criteria

Qualifiers

Have a designated community physician responsible for primary care who is capable of using a smartphone with stable internet access for clinical communication and LLM-assisted management;

No plan for administrative merger or restructuring within the next three years;

Located at least 2 kilometers away from adjacent participating communities (to minimize contamination between clusters).

Aged 40 years or older;

Disqualifiers

None

Trial design

Treatments tested in this trial

  • LLM-Enabled Co-management

Treatment groups

6,800 Participants
are divided into 2 treatment groups

Sponsors and collaborators

First Hospital of China Medical University

Lead sponsor

Beijing Chao Yang Hospital

Collaborator

Zhejiang University

Collaborator

Shandong Provincial Hospital

Collaborator

Cangzhou Central Hospital

Collaborator